0049-3190 : Vfend 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC0049-3190
Labeler: Roerig
Product Type: Human Prescription Drug
Drug Name:  Vfend
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: NDA021267
Rev. Date: 


NDC Package Codes:

  • 0049-3190-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (0049‑3190‑01) > 20 ML IN 1 VIAL, SINGLE‑USE
  • 0049-3190-28: 20 ML IN 1 VIAL, SINGLE‑USE (0049‑3190‑28)
  • 0049-3190-38: 20 ML IN 1 VIAL, SINGLE‑USE (0049‑3190‑38)

Active Ingredients:

  • Voriconazole

Dosage Strength:

  • 10 mg/mL

Pharmaceutical Classes:

  • Azole Antifungal [EPC]
  • Azoles [CS]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 2C19 Inhibitors [MoA]
  • Cytochrome P450 2C9 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0049-3160 Vfend 40 mg/ml Oral Powder, for Suspension by Roerig
  • 0049-3170 Vfend 50 mg Oral Tablet by Roerig
  • 0049-3180 Vfend 200 mg Oral Tablet by Roerig
  • 0049-4190 Vfend 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Roerig
  • 55154-2725 Vfend 200 mg Oral Tablet by Cardinal Health
  • 55154-2730 Vfend 50 mg Oral Tablet by Cardinal Health

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0049-3190 QR Code

< Prev: 0049-3180Next: 0049-3410 >

Related Discussions:

Voriconazole and sun sensitivity
Does anyone have experience with skin sun sensitivity and extended voriconazole use for propholactic purposes (in immune... 3 replies
Voriconazole use problems!
Just finished my first 4 months on Vori & prednisone. Other than what my docs tell me I have no other source to find...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.